logo
MS-based methods for biomarkers of Parkinson's disease: what is the future?
Bioanalytical laboratory automation development: why should we and how could we collaborate?
Metabolic profiling of epithelial ovarian cancer cell lines: evaluation of harvesting protocols for profiling using NMR spectroscopy
Quantitation of 25-hydroxyvitamin D2 and D3 in serum and plasma by LCMS/MS
Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod
Determination of riociguat and its major human metabolite M-1 in human plasma by stable-isotope dilution LCMS/MS
Simultaneous determination of levodopa, carbidopa, entacapone, tolcapone, 3- O -methyldopa and dopamine in human plasma by an HPLC–MS/MS method
Justifying the lack of incurred sample reproducibility in a study: considerations and strategies
Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development
Enrichment of phosphorylated peptides and proteins by selective precipitation methods
Detection of the disease-associated form of the prion protein in biological samples
SERS-based approaches toward genetic profiling